Showing 1 - 10 results of 10 for search 'S. V. Glagolev', query time: 0.01s Refine Results
  1. 1
    Monitoring of drug safety

    Monitoring of drug safety by B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022

    Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022 by A. V. Matveev, S. V. Glagolev, K. N. Koryanova, D. A. Sychev

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Typical pharmacovigilance system master file (PSMF)

    Typical pharmacovigilance system master file (PSMF) by B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results

    Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results by Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, S. V. Glagolev

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Guidelines for the planning and implementation of pharmacovigilance systems audit

    Guidelines for the planning and implementation of pharmacovigilance systems audit by S. V. Glagolev, Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Perfection of management principles by the safety signals of medicinal products

    Perfection of management principles by the safety signals of medicinal products by B. K. Romanov, V. K. Lepakhin, E. O. Zhuravleva, A. V. Astakhova, S. V. Glagolev, V. A. Polivanov

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease

    Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease by N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev

    Published 2023-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

    ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS by N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis

    Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thro... by l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review

    Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review by A. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, A. V. Matveev, V. I. Vechorko, O. V. Averkov, S. V. Glagolev, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, D. A. Sychev

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: